Researchers at the University of California, Riverside (UCR) have unveiled a groundbreaking discovery in the ongoing battle against drywood termites,…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More
Datroway Receives FDA Approval for Metastatic Triple-Negative Breast Cancer, Marking a Significant Advancement in Targeted Therapy
The US Food and Drug Administration (FDA) has granted a pivotal approval for Datroway (datopotamab deruxtecan), a novel antibody-drug conjugate…
Read More
WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.
The World Health Organization (WHO) has unveiled a suite of groundbreaking recommendations aimed at revolutionizing tuberculosis (TB) diagnostics, promising faster,…
Read More
Cornell University Scientists Develop Breakthrough Reversible Nonhormonal Male Contraceptive Through Targeted Meiotic Disruption
In a significant advancement for reproductive medicine, a team of researchers at Cornell University has announced a major breakthrough in…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – In a significant development offering renewed hope in the challenging landscape of brain cancer treatment, researchers…
Read More
A Groundbreaking Discovery Offers a Targeted Approach to Eradicating Drywood Termites by Disrupting Their Molting Process
Researchers at the University of California, Riverside, have unveiled a promising new strategy for combating drywood termite infestations, a pervasive…
Read More
WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.
The World Health Organization (WHO) has unveiled a groundbreaking set of new recommendations designed to fundamentally transform tuberculosis (TB) diagnostics,…
Read More
AstraZeneca’s Targeted Treatment Offers New Hope for Stomach Cancer Patients in the UK
AstraZeneca’s groundbreaking targeted therapy, Imfinzi (durvalumab), has secured a pivotal recommendation from the National Institute for Health and Care Excellence…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
In a significant stride forward against one of the most formidable and lethal human cancers, researchers at UCLA have successfully…
Read More
